Kirby McInerney LLP Alerts Investors Who Acquired Capricor Therapeutics, Inc. CAPR Securities Between December 17, 2025 and July 26, 2026 of Pending Lawsuit

Law firm Kirby McInerney LLP is alerting investors about pending securities fraud class action lawsuits against Capricor Therapeutics, Rackspace Technology, and Bloom Energy. The primary focus is on Capricor, which faces allegations of making false statements regarding changes to its statistical analysis plan for the Deramiocel drug candidate without FDA approval. The FDA subsequently rejected the drug, causing Capricor's stock to plummet 64% on July 27, 2026, and an additional 36% on July 30, 2026. The lead plaintiff deadline is September 28, 2026.